Home › Funds › BANQUE PICTET & CIE SA › GENB
BANQUE PICTET & CIE SA position in GENB
GENERATE BIOMEDICINES INC · Health Care
BANQUE PICTET & CIE SA reported holding 1,773,043 shares of GENB (GENERATE BIOMEDICINES INC) in its Q3 2026 13F filing — a position valued at US$26.6M, representing 0.39% of its reported portfolio and ranking #49 among its reported holdings. BANQUE PICTET & CIE SA first reported this position in Q3 2026.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How BANQUE PICTET & CIE SA's GENB position evolved
BANQUE PICTET & CIE SA first disclosed a stake in GENB in Q3 2026 at 1,773,043 shares (US$26.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.77M | $26.63M | New |
About GENB and 13F data
GENB (GENERATE BIOMEDICINES INC) is a Health Care company. 96 other funds we track also report a position in GENB — the largest reported positions include Flagship Pioneering, LLC (US$1.06B), BRAIDWELL LP (US$55.4M), ARCH Venture Management, LLC (US$32.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENB
- Flagship Pioneering, LLC 62.67M sh · $1.06B · Q2 2026
- BRAIDWELL LP 3.28M sh · $55.40M · Q2 2026
- ARCH Venture Management, LLC 1.94M sh · $32.80M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.72M sh · $29.05M · Q2 2026
- Harvard Management Company 1.11M sh · $18.74M · Q2 2026
- HARVARD MANAGEMENT CO INC 1.11M sh · $18.74M · Q2 2026
- NVIDIA CORP 833.33K sh · $14.06M · Q2 2026
- Davern Capital Partners, LP 824.68K sh · $13.91M · Q2 2026
More on BANQUE PICTET & CIE SA
FAQ
How long has BANQUE PICTET & CIE SA held GENB?
BANQUE PICTET & CIE SA has disclosed GENB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is BANQUE PICTET & CIE SA's current position in GENB?
As of Q3 2026, BANQUE PICTET & CIE SA holds 1.77M shares of GENB (GENERATE BIOMEDICINES INC), valued at $26.63M, representing 0.39% of its reported portfolio and ranking #49.
Has BANQUE PICTET & CIE SA been buying or selling GENB?
In the latest 13F filing (Q3 2026), BANQUE PICTET & CIE SA newly opened its position in GENB.
Which other funds hold GENB?
Other major institutional holders of GENB include Flagship Pioneering, LLC, BRAIDWELL LP, ARCH Venture Management, LLC, among 96 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.